title: Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
abstract: Mucosal immune responses are the first-line defensive mechanisms against a variety of infections. Therefore, immunizations of mucosal surfaces from which majority of infectious agents make their entry, helps to protect the body against infections. Hence, vaccinization of mucosal surfaces by using mucosal vaccines provides the basis for generating protective immunity both in the mucosal and systemic immune compartments. Mucosal vaccines offer several advantages over parenteral immunization. For example, (i) ease of administration; (ii) non-invasiveness; (iii) high-patient compliance; and (iv) suitability for mass vaccination. Despite these benefits, to date, only very few mucosal vaccines have been developed using whole microorganisms and approved for use in humans. This is due to various challenges associated with the development of an effective mucosal vaccine that can work against a variety of infections, and various problems concerned with the safe delivery of developed vaccine. For instance, protein antigen alone is not just sufficient enough for the optimal delivery of antigen(s) mucosally. Hence, efforts have been made to develop better prophylactic and therapeutic vaccines for improved mucosal Th1 and Th2 immune responses using an efficient and safe immunostimulatory molecule and novel delivery carriers. Therefore, in this review, we have made an attempt to cover the recent advancements in the development of adjuvants and delivery carriers for safe and effective mucosal vaccine production.
authors: Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Mysore, India.
authors: Atul
authors: A
authors: Srivastava
authors: Devegowda Vishakante
authors: DV
authors: Gowda
authors: SubbaRao V
authors: SV
authors: Madhunapantula
authors: Chetan G
authors: CG
authors: Shinde
authors: Meenakshi
authors: M
authors: Iyer
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D016207:Cytokines / Q000008:administration & dosage / Q000276:immunology; D004337:Drug Carriers; D006801:Humans; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000276:immunology; D009092:Mucous Membrane / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D004337:Drug Carriers; D007070:Immunoglobulin A; D014612:Vaccines
keywords: Mucosal vaccines; antigen delivery; immune response; mucosal adjuvant